HUTCHMED receives China approval for ORPATHYS in gastric cancer

Markets Investing.com By Investing.com 02 Jul 2026 08:32 1 min read

HUTCHMED receives China approval for ORPATHYS in gastric cancer

HUTCHMED receives China approval for ORPATHYS in gastric cancer

HUTCHMED receives China approval for ORPATHYS in gastric cancer

Read the full story on Investing.com → Opens the original article on www.investing.com

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.